Skip to main content
Log in

Salicylate protein binding in serum from young and elderly subjects as measured by diafiltration

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The protein binding of salicylate was measured by continuous ultrafiltration (diafiltration) at 22°C in serum obtained from 5 healthy young (mean age: 27 years) and 5 healthy elderly (mean age: 73 years) male volunteers. Unbound salicylate increased disproportionately with increasing total salicylate concentration, up to 7000 µmol, in all sera. The fraction bound of salicylate was significantly lower in sera from elderly but this was not due to decreased albumin or total protein concentrations. The binding of salicylate to serum proteins was characterized by two classes of binding sites. The high affinity site had an association constant of either 94901/mol (young) or 75601/mol (elderly) and the number of binding sites was either 4.7 (young) or 3.7 (elderly). The total binding capacity of the low affinity site, 1121/mol, in sera from elderly was significantly less than the binding capacity, 631l/mol, in sera from young. Differences in binding capacity of the low affinity site partially accounted for a two to three-fold increase in the salicylate free fraction in elderly sera. These data suggest that age-related differences in serum protein binding may influence salicylate pharmacokinetics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bayles TB (1969) Salicylate therapy in rheumatoid arthritis. Med Clin North Am 52: 703–706

    Google Scholar 

  2. Blatt WF, Robinson SM, Bixler JJ (1968) Membrane ultrafiltration: the diafiltration technique and its application to microsolute exchange and binding phenomena. Anal Biochem 26: 151–173

    Google Scholar 

  3. Borga O, Odar-Cederlof I, Ringberger V, Norlin A (1976) Protein binding of salicylate in uremic and normal plasma. Clin Pharmacol Ther 20: 464–475

    Google Scholar 

  4. Campion DS, Olsen R (1974) Measurement of drug displacement by continuous ultrafiltration. J Pharm Sci 63: 247–252

    Google Scholar 

  5. Costello PB, Green FA, Jung CY (1982) Free versus bound salicylate concentration in adults and children with chronic inflammatory joint disease. Arthritis Rheum 25: 32–37

    Google Scholar 

  6. Cuny G, Royer RJ, Mur JM, Serot JM, Faure G, Netten P, Maillard A, Pein F (1979) Pharmacokinetics of salicylates in the elderly. Gerontology 25: 49–55

    Google Scholar 

  7. Ekstrand R, Alvan G, Borga O (1979) Concentration dependent plasma protein binding of salicylate in rheumatoid patients. Clin Pharmacokin et 4: 137–143

    Google Scholar 

  8. Furst DE, Tozer TN, Melmon KL (1979) Salicylate clearance, the resultant of protein binding and metabolism. Clin Pharmacol Ther 26: 380–389

    Google Scholar 

  9. Geddes R, White PM (1978) Drug binding in human serum albumin as assayed by diafiltration and fluorimetry. Biochem Pharmacol 28: 2285–2288

    Google Scholar 

  10. Gram L, Flachs H, Wurtz-Jorgensen A, Parnas J, Anderson B (1979) Sodium valproate, serum level and clinical effect in epilepsy: a controlled study. Epilepsia 20: 303–313

    Google Scholar 

  11. Greenblatt DJ (1979) Reduced serum albumin concentration in the elderly: a report from the Boston Collaborative Drug Surveillance Program. J Am Geriatr Soc 27: 20–22

    Google Scholar 

  12. Greenblatt DJ, Sellers EM, Shader RI (1982) Drug disposition in old age. N Engl J Med 306: 1081–1088

    Google Scholar 

  13. Greenblatt DJ, Sellers EM, Koch-Weser J (1982) Importance of protein binding for the interpretation of serum or plasma drug concentrations. J Clin Pharmacol 22: 259–263

    Google Scholar 

  14. Greene DS, Nightingale CH (1976) A new method of calculating protein binding parameters obtained from diafiltration methods. Acad Pharm Sci Abstr 6: 117

    Google Scholar 

  15. Hayes MJ, Langman MJS, Short AH (1975) Changes in drug metabolism with increasing age; 1. Warfarin binding and plasma proteins. Br J Clin Pharmacol 2: 69–72

    Google Scholar 

  16. Klotz I (1982) Number of receptor sites from Scatchard graphs: facts and fantasies. Science 217: 1347–1349

    Google Scholar 

  17. Levy G (1965) Pharmacokinetics of salicylate elimination in man. J Pharm Sci 54: 959–967

    Google Scholar 

  18. Mather LE, Tucker GT, Pflug AE, Linorop MJ, Wilkerson C (1975) Meperidine kinetics in man; intravenous injection in surgical patients and volunteers. Clin Pharmacol Ther 17: 21–30

    Google Scholar 

  19. McMenamy RH, Dintzis HM, Watson F (1971) Cyanogen bromide fragments of human serum albumin. J Biol Chem 246: 4744–4750

    Google Scholar 

  20. Meffin PJ, Robert RW, Windle RA, Harapat S, Peters FA, Harrison DC (1979) Role of concentration dependent plasma protein binding in disopyramide disposition. J Pharmacokinet Biopharm 7: 29–46

    Google Scholar 

  21. Meyers EN, Bernstein JM, Fostiropolous G (1965) Salicylate ototoxicity. N Engl J Med 273: 587–590

    Google Scholar 

  22. Miller AK, Adir J, Vestal RE (1978) Tolbutamide binding to plasma proteins of young and old human subjects. J Pharm Sci 67: 1192–1193

    Google Scholar 

  23. Morgan E, Kelly P, Nies K, Porter WW, Paulus HE (1973) Tinnitus as an indicator of therapeutic serum salicylate levels. J Am Med Assoc 226: 142–145

    Google Scholar 

  24. Ouslander J (1981) Drug therapy in the elderly. Ann Intern Med 95: 711–722

    Google Scholar 

  25. Pickart L (1983) Increased ratio of plasma free fatty acids during normal aging and in patients with coronary heart disease. Atherosclerosis 46: 21–28

    Google Scholar 

  26. Rubin GM, Tozer TN, Oie S (1983) Concentration dependence of salicylate distribution. J Pharm Pharmacol 35: 115–117

    Google Scholar 

  27. Scatchard G (1949) The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51: 660–672

    Google Scholar 

  28. Schwartz PA, Greene DS, Rhodes CT (1980) Effect of sodium oleate on salicylic acid binding to human serum albumin. J Pharm Sci 69: 1345–1347

    Google Scholar 

  29. Shah VP, Wallace SM, Riegelman S (1974) Microultrafiltration technique for drug-protein binding determination in plasma. J Pharm Sci 63: 1364–1367

    Google Scholar 

  30. Steele WH, Boobis SW, Moore MR, Goldberg A, Brodie MJ (1978) Protein binding of salicylate in cutaneous hepatic porphyria. Eur J Clin Pharmacol 13: 309–313

    Google Scholar 

  31. Wallace S, Whiting B (1976) Factors affecting drug binding in plasma of elderly patients. Br J Clin Pract 3: 327–330

    Google Scholar 

  32. Wosilait WD (1976) Theoretical analysis of the binding of salicylate by human serum albumin: the relationship between free and bound drug and therapeutic levels. Eur J Clin Pharmacol 9: 285–290

    Google Scholar 

  33. Zaroslinski JF, Keresztes-Nagy S, Mais RF, Oester YT (1974) The effect of temperature on the binding of salicylate by human serum albumin. Biochem Pharmacol 23: 1767–1776

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lesko, L.J., Narang, P.K., Yeager, L. et al. Salicylate protein binding in serum from young and elderly subjects as measured by diafiltration. Eur J Clin Pharmacol 28, 339–345 (1985). https://doi.org/10.1007/BF00543334

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00543334

Key words

Navigation